We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
-17.62%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$331M
AUM Growth
-$155M
Cap. Flow
-$54.9M
Cap. Flow %
-16.56%
Top 10 Hldgs %
21.54%
Holding
166
New
14
Increased
53
Reduced
62
Closed
35

Top Buys

Rank Stock Value
1
ALE
Allete
ALE
+$5.64M
2
MGRC icon
McGrath RentCorp
MGRC
+$4.54M
3
DECK icon
Deckers Outdoor
DECK
+$2.68M
4
KBH icon
KB Home
KBH
+$2.68M
5
ESNT icon
Essent Group
ESNT
+$2.59M

Sector Composition

Rank Sector Weight
1 Industrials 17.05%
2 Healthcare 16.63%
3 Technology 15.75%
4 Financials 14.08%
5 Consumer Discretionary 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYNB
76
Kyntra Bio
KYNB
$29.4M
$1.61M 0.49%
+1,855
New +$1.84M
HQY icon
77
HealthEquity
HQY
$8.75B
$1.6M 0.48%
31,628
+1,033
+3% +$68.6K
SHOO icon
78
Steven Madden
SHOO
$3.55B
$1.54M 0.47%
66,512
-102
-0.2% -$3.54K
ASND icon
79
Ascendis Pharma A/S
ASND
$16.8B
$1.54M 0.47%
13,703
-4,442
-24% -$577K
EFOR
80
Everforth Inc
EFOR
$1.32B
$1.51M 0.46%
42,712
+676
+2% +$38.3K
NTRA icon
81
Natera
NTRA
$46.4B
$1.5M 0.45%
50,343
-69
-0.1% -$2.31K
DRNA
82
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.47M 0.44%
79,842
-119
-0.1% -$2.31K
AZTA icon
83
Azenta
AZTA
$1.48B
$1.42M 0.43%
46,535
-110
-0.2% -$4K
TROW icon
84
T. Rowe Price
TROW
$24.3B
$1.38M 0.42%
14,106
+6,966
+98% +$853K
CNMD icon
85
CONMED
CNMD
$1.47B
$1.36M 0.41%
23,720
-50
-0.2% -$4.61K
WHD icon
86
Cactus
WHD
$5.44B
$1.33M 0.4%
114,918
+6,353
+6% +$160K
RS icon
87
Reliance Steel & Aluminium
RS
$21.6B
$1.31M 0.4%
14,949
+7,502
+101% +$800K
NGVT icon
88
Ingevity
NGVT
$2.68B
$1.3M 0.39%
36,849
+831
+2% +$48.5K
LUV icon
89
Southwest Airlines
LUV
$23B
$1.15M 0.35%
32,378
+18,572
+135% +$921K
MNTA
90
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.09M 0.33%
+40,225
New +$1.12M
RETA
91
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.06M 0.32%
7,351
-8,121
-52% -$1.57M
RHI icon
92
Robert Half
RHI
$4.37B
$1.05M 0.32%
27,796
+12,479
+81% +$676K
BLK icon
93
Blackrock
BLK
$176B
$923K 0.28%
+2,097
New +$1.03M
COF icon
94
Capital One
COF
$134B
$878K 0.27%
17,413
+6,833
+65% +$601K
MET icon
95
MetLife
MET
$62.1B
$819K 0.25%
26,775
+15,344
+134% +$680K
THG icon
96
Hanover Insurance
THG
$7.98B
$804K 0.24%
8,876
+4,327
+95% +$535K
MGA icon
97
Magna International
MGA
$18.8B
$795K 0.24%
25,200
+14,100
+127% +$650K
JNJ icon
98
Johnson & Johnson
JNJ
$625B
$735K 0.22%
5,603
+983
+21% +$139K
BEN icon
99
Franklin Resources
BEN
$17.2B
$733K 0.22%
43,933
+15,620
+55% +$359K
WNS
100
DELISTED
WNS Holdings
WNS
$732K 0.22%
+17,034
New +$1.09M

Similar funds

Moody Aldrich Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Moody Aldrich Partners held 166 positions worth $331M, down 32% from $487M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Moody Aldrich Partners withdrew a net $54.9M in Q1 2020, closing 35 positions and reducing 62 holdings. Its most notable exit was iShares MSCI ACWI ETF, an estimated $45.9M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Moody Aldrich Partners opened a new position in Allete worth $4.52M.

  • Moody Aldrich Partners's largest Q1 2020 buy was Allete: 74,535 shares worth $4.52M.
  • Moody Aldrich Partners added most to KB Home in Q1 2020, an estimated $2.68M increase.
  • Moody Aldrich Partners's biggest Q1 2020 reduction was Esperion Therapeutics, cutting an estimated $1.87M.
  • Moody Aldrich Partners fully exited iShares MSCI ACWI ETF in Q1 2020, selling an estimated $45.9M.
  • Moody Aldrich Partners's ten largest holdings make up 22% of its $331M portfolio in Q1 2020.
  • Moody Aldrich Partners opened 14 new positions and closed 35 in Q1 2020.
  • Moody Aldrich Partners's portfolio value fell 32% quarter-over-quarter to $331M.

Based on Moody Aldrich Partners's 13F filing for Q1 2020, filed 7 May 2020.